bay x 1005 has been researched along with Disease Models, Animal in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Arroyo, V; Clària, J; Gaya, J; González-Périz, A; López-Parra, M; Miquel, R; Planagumà, A; Rodés, J; Titos, E | 1 |
| Medvedeff, ED; Nickerson-Nutter, CL | 1 |
| Burchardt, ER; Müller-Peddinghaus, R | 1 |
| Henseleit, U; Rescher, U; Schönlau, F; Sorg, C; Steinbrink, K; Sunderkötter, C; Vogel, T | 1 |
5 other study(ies) available for bay x 1005 and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Arachidonate 5-Lipoxygenase; Carbon Tetrachloride; Carrier Proteins; Cell Count; Chemical and Drug Induced Liver Injury; Chronic Disease; Disease Models, Animal; Hepatocytes; Kupffer Cells; Leukotrienes; Lipoxins; Lipoxygenase Inhibitors; Liver; Liver Diseases; Male; Matrix Metalloproteinase 2; Membrane Proteins; Quinolines; Rats; Rats, Wistar; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-2 | 2005 |
The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Chronic Disease; Disease Models, Animal; Drug Combinations; Exudates and Transudates; Female; Hydroxyurea; Inflammation; Leukotriene B4; Lipoxygenase; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Naproxen; Prostaglandin-Endoperoxide Synthases; Quinolines; Time Factors; Zymosan | 1996 |
Antiedematous effects of combination therapies with the leukotriene synthesis inhibitor BAY X 1005 in the archidonic acid-induced mouse ear inflammation test.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Disease Models, Animal; Drug Therapy, Combination; Ear; Edema; Female; Histamine H1 Antagonists; Indomethacin; Inflammation; Lipoxygenase Inhibitors; Methysergide; Mice; Mice, Inbred Strains; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrilamine; Quinolines; Serotonin Antagonists | 1997 |
Ineffective elimination of Leishmania major by inflammatory (MRP14-positive) subtype of monocytic cells.
Topics: Animals; Anti-Inflammatory Agents; Antigens, Differentiation; Calgranulin B; Cells, Cultured; Dexamethasone; Disease Models, Animal; Female; Immunohistochemistry; In Vitro Techniques; Interferon-gamma; Leishmania major; Leishmaniasis, Cutaneous; Lymph Nodes; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microscopy, Fluorescence; Monocytes; Phagocytosis; Quinolines; S100 Proteins; Spleen | 2000 |